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RESEARCH ARTICLE
Variations in IL-23 and IL-25 receptor 
gene structure, sequence and expression 
associated with the two disease forms of sheep 
paratuberculosis
Louise Nicol1, Anton Gossner1, Craig Watkins2, Francesca Chianini2, Robert Dalziel1 and John Hopkins1*
Abstract 
The immunopathology of paucibacillary and multibacillary sheep paratuberculosis is characterized by inflammatory T 
cell and macrophage responses respectively. IL-23 and IL-25 are key to the development of these responses by inter-
action with their complex receptors, IL-23R/IL-12RB1 and IL-17RA/IL-17RB. In humans, variations in structure, sequence 
and/or expression of these genes have been implicated in the different pathological forms of tuberculosis and lep-
rosy, and in gastrointestinal inflammatory disorders such as Crohn’s disease. Sequencing has identified multiple tran-
script variants of sheep IL23R, IL12RB1 and IL17RB and a single IL17RA transcript. RT-qPCR assays were developed for 
all the identified variants and used to compare expression in the ileo-caecal lymph node of sheep with paucibacillary 
or multibacillary paratuberculosis and uninfected animals. With IL-23 receptor, only the IL12RB1v3 variant, which lacks 
the receptor activation motif was differentially expressed and was significantly increased in multibacillary disease; this 
may contribute to high Th2 responses. Of the IL17RB variants only full length IL17RB was differentially expressed and 
was significantly increased in multibacillary pathology; which may also contribute to Th2 polarization. IL17RA expres-
sion was significantly increased in paucibacillary disease. The contrast between the IL17RA and IL17RB results may 
indicate that, in addition to Th1 cells, Th17 T cells are also involved in paucibacillary pathology.
© 2016 Nicol et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Paratuberculosis (Johne’s disease) is an endemic enteric 
disease of ruminants caused by Mycobacterium avium 
subspecies paratuberculosis (MAP) [1]; and like human 
mycobacterial infections, clinical paratuberculosis 
develops in a minority of infected animals [2]. In sheep, 
approximately one-third of the diseased animals develop 
paucibacillary or tuberculoid pathology and two-thirds 
develop multibacillary or lepromatous disease [2]; with 
lesions localized largely in the lamina propria of the ter-
minal ileum [2]. Paucibacillary pathology is characterized 
by lymphocyte infiltration, granulomatous inflammation 
and few bacteria. In contrast multibacillary lesions are 
composed largely of heavily infected macrophages [2]. 
There is progression from sub-clinically infected to pauc-
ibacillary disease and terminal multibacillary pathology 
[3]; however progression occurs less frequently in sheep 
than in cattle and paucibacillary disease is usually fatal in 
infected sheep [2, 4, 5].
The immunology of paratuberculosis in sheep is also 
similar to tuberculoid and lepromatous forms of the 
human mycobacterial diseases, tuberculosis and leprosy 
[6, 7]. Paucibacillary disease is associated with a highly 
polarized Th1/Th17 response, characterized by high lev-
els of IL-12, IL-17A and IFNγ [8–10]; and multibacillary 
paratuberculosis is linked with a strong Th2 response 
with high levels of IL-5 and IL-10 [8–11]. MAP has also 
been implicated as an aetiological agent of inflammatory 
intestinal diseases in humans because of the apparent 
similarity between the pathology of paucibacillary para-
tuberculosis and Crohn’s disease [12]. Like the human 
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mycobacterial diseases, the epidemiology of paratuber-
culosis strongly suggests a host genetic susceptibility to 
disease severity and pathological form [13, 14]. Many of 
the genes associated with severity of human disease and 
pathology belong to the pathways that control differen-
tial T cell activation [13]; and genes in these pathways 
are also linked to gastrointestinal inflammatory diseases 
including ulcerative colitis and Crohn’s disease [12–15].
Of particular interest in this study are genes for the 
cytokines and cytokine receptors that control the expres-
sion of Th1, Th17 and Th2 subsets associated with the dif-
ferent forms of chronic gastrointestinal inflammation [15, 
16] and are also important in the pathogenesis of tuber-
culosis and leprosy [7–13]. The activation of Th1/Th17 T 
cells is regulated by the interaction of the related heter-
odimeric cytokines IL-12 and IL-23 with their respective 
receptor complexes, IL-12RB1/IL-12RB2 and IL-12RB1/
IL-23R [17]. Macrophages play a critical role in the pres-
entation of antigen to T cells and their downstream acti-
vation and polarization, and are the target cells for MAP 
infection [18]. Mycobacterial infection of macrophages 
affects the expression of IL-12 and IL-23 [8, 19, 20] and 
therefore potentially influences the polarization of the 
immune response and consequently disease pathology. 
In contrast, the activation of Th2 T cells is influenced by 
IL-25 [21], which is produced by cells such as intestinal 
epithelium and innate lymphoid cells 2 (ILC2) and func-
tions by interacting with its complex receptor IL-17RA/
IL-17RB on T cells [22].
Variations in gene structure, sequence or expression 
levels of these cytokines and their receptors have been 
implicated in human mycobacterial pathogenesis and/
or gastrointestinal and respiratory inflammatory diseases 
[13, 23]. Genome wide association studies have identi-
fied the association of single nucleotide polymorphisms 
(SNPs) of IL12B and IL23R with susceptibility to leprosy 
and tuberculosis [13, 24] and with Crohn’s disease [16]. In 
addition, specific splice variants of IL12B and IL23R have 
been linked to disseminated BCG infection [25] and with 
inflammatory bowel disease [26]. Studies on IL-25 and its 
receptor complex have found similar associations with 
inflammation; SNP analysis of IL17RA has linked three 
alleles associated with aspirin exacerbated respiratory dis-
ease [27] and IL17RB polymorphisms with asthma [28].
The aims of this study were to characterize the differ-
ent sequence and transcript variants of the sheep IL-23 
and IL-25 receptor complexes associated with Th1/Th17 
and Th2 T cell polarization within the ileo-caecal lymph 
node (ICLN), the major immune inductive site for patho-
gens infecting the terminal ileum [29]; and to assess the 
expression of the different transcript variants in relation 
to defined paucibacillary and multibacillary pathology of 
sheep paratuberculosis.
Materials and methods
Animals, disease diagnosis and tissue collection
Animals with clinical paratuberculosis were out-bred 
Blackface or Blackface cross female sheep with natu-
rally acquired MAP infection sourced from six farms; 
uninfected controls were from a single source with no 
history of paratuberculosis. The pathology of paratuber-
culosis was confirmed in clinically-affected sheep at post-
mortem, by haematoxylin and eosin and Ziehl–Neelsen 
histopathology of the terminal ileum, MLN and ICLN. 
Infection was confirmed in affected sheep by IS900 
PCR; all control sheep were IS900 negative (Table  1). 
There were six animals in each of three groups. Tissue 
was ICLN, removed immediately post-mortem, cut into 
blocks of ~0.5 g and placed in five volumes of RNAlater 
(Ambion, Huntingdon, UK), which were then incubated 
overnight at 4 °C and stored at −80 °C. No animals were 
euthanized specifically for this study; the animals were 
humanely culled for clinical reasons of paratuberculosis 
disease or for reasons unrelated to this study (uninfected 
controls).
IS900 quantitative PCR
ICLN of all animals was tested for the presence of MAP 
by PCR for insertion sequence IS900. Two independent 
primer sets were used [30, 31]; set 1 generated an ampli-
con of 99  bp (for: GTTCGGGGCCGTCGCTTAGG; 
rev: GCGGGCGGCCAATCTCCTT) and set 2 gener-
ated a product of 314  bp (for: CTGGCTACCAAACTC 
CCGA; rev: GAACTCAGCGCCCAGGAT). Genomic 
DNA (gDNA) was purified using the Wizard® Genomic 
DNA Purification Kit (Promega, UK). All reactions used 
FastStart Taq DNA Polymerase (Roche Diagnostics, UK) 
following the manufacturer’s instructions, with 500 ng of 
gDNA and 0.2 μM of each primer. PCRs were performed 
using a Veriti® Thermal Cycler (Applied Biosystems) 
with four separate reactions performed for each primer 
set at different annealing temperatures. PCR reactions 
consisted of a heat activation step for 5 min at 95 °C, 35 
cycles of 15 s at 95 °C, 15 s at 55, 58, 60 and 62 °C, and 
30  s at 72  °C, with a final elongation step of 10  min at 
72 °C.
PCR products were analysed on a 2% agarose gel 
electrophoresis, purified with a MinElute Gel Extrac-
tion Kit (Qiagen, UK) according to the manufacturer’s 
instructions; cloned using a TOPO TA cloning kit for 
sequencing (Invitrogen) and sequenced using BigDye 
Terminator v3.1 Cycle Sequencing Kit and 3730 DNA 
Analyser (Applied Biosystems). The presence of an ampli-
con, confirmed by sequencing, from either primer set 
was taken as a positive result for the presence of MAP; 
the absence of an amplicon in all PCR reactions was con-
firmation of absence of MAP infection. All multibacillary 
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and paucibacillary animals were positive and all unin-
fected, control animals were negative for IS900.
Cloning of ovine gene fragments
RNA was isolated from ~20  mg of ICLN using the 
Ribopure Kit (Ambion, UK) according to the manufac-
turers’ instructions. Genomic DNA was removed by 
On-column PureLink® DNase I treatment (Ambion). 
RNA quantity, quality and integrity were determined 
using a Labtech NanoDrop ND-1000 spectrophotom-
eter and Agilent 2200 TapeStation system; samples had 
an RNA Integrity Number of 7.4–9. cDNA was synthe-
sised from 1.0  μg RNA using SuperScript™ II RT with 
RNaseOUT (Invitrogen, UK) and oligo-dT(15) primer 
(Promega, UK), in 20  μL final volume. The predicted 
sequences of the sheep genes were obtained by NCBI-
BLAST of the bovine (or if bovine sequences were not 
available, human and/or mouse) sequences against the 
Oar v3.1 sheep genome assembly [32]. Primers were 
selected using Primer-BLAST [33] and reanalysed using 
Net Primer [34]. The primers were used to amplify over-
lapping sections of genes, with at least 100 bp overlap of 
amplicons; each primer set was used in RT-PCR using 
FastStart Taq (Roche, UK) as per manufacturer’s instruc-
tions. New primers were selected (Additional file  1) 
from these assembled sequences to obtain full length 
transcripts using Platinum® Taq DNA Polymerase 
High Fidelity (Invitrogen). PCR products were purified 
using a MinElute PCR Purification Kit (Qiagen), ligated 
into pGEM®-T Easy Vector (Promega). Plasmids were 
extracted using QIAprep Spin MiniPrep Kit (Qiagen) fol-
lowing the manufacturers’ protocol. At least three clones 
from all diseased sheep, for each insert, were sequenced 
using T7 and SP6 primers, with BigDye® Terminator v3.1 
Cycle Sequencing Kit (Applied Biosystems, UK). The 
GeneRacer™ Kit for full-length, RNA ligase-mediated 
rapid amplification of 5′ and 3′ cDNA ends (Invitrogen) 
was used to sequence the 5′ and 3′ untranslated region 
(UTR).
Quantitative real‑time RT‑PCR analysis
Primers for quantitative real-time RT-PCR (RT-qPCR) 
were selected and optimized for all genes and variants 
(Additional file  2). Primers were designed overlapping 
Table 1 Breed, age, histopathology and disease diagnosis of sheep
a Source farms.
b Severity of granulomatous inflammation (SGI) grading: based on total number of epithelioid macrophages and leukocyte distribution patterns of the terminal ileum 
[5].
c Acid fast bacteria (AFB) -; grading: grades 0–2 were defined as paucibacillary; grades 3–4 were defined as multibacillary observed in terminal ileum tissue [5].
d Tissue specific lesion grading: for each terminal ileum histological section, the sum of the points (SGI + AFB) was used to determine tissue-specific lesion grades. A 
severity of “none” was assigned to those with a lesion grade of 0, “mild” was assigned to a lesion grade of ≥2 and ≤3, “moderate” was assigned to those with a lesion 
grade of >3 and ≤5 and “severe” was assigned to a lesion grade of 6–11.
e IS900 PCR result using each of the two primer sets.
f Diagnosis: based on histopathological observations.
Sheep ID Breed Origina Age (years) SGIb AFBc Tissue specific lesion graded IS900e Diagnosisf
SH.139 Blackface A 3 5 4 Severe +, + Multibacillary
SH.140 Blackface A 3 7 4 Severe +, + Multibacillary
SH.146 Blackface x B 2.5 5 4 Severe +, + Multibacillary
SH.190 Blackface C 3 5 4 Severe +, + Multibacillary
SH.199 Blackface C 2 6 4 Severe +, + Multibacillary
SH.204 Blackface D 1.5 6 4 Severe +, + Multibacillary
SH.107 Blackface x E 2.5 2.5 0 Mild +, + Paucibacillary
SH.147 Blackface x B 2 3 0 Mild +, + Paucibacillary
SH.155 Blackface F 3 2 0 Mild +, + Paucibacillary
SH.160 Blackface x B 3 2.5 0 Mild +, + Paucibacillary
SH.188 Blackface x B 4 4 1 Moderate +, + Paucibacillary
SH.205 Blackface D 4 2 0 Mild +, + Paucibacillary
K207 Blackface G 2.5 0 0 ND −, − Control
K208 Blackface G 2.5 0 0 ND −, − Control
K213 Blackface G 2.5 0 0 ND −, − Control
K224 Blackface G 2.5 0 0 ND −, − Control
K227 Blackface G 2.5 0 0 ND −, − Control
K229 Blackface G 2.5 0 0 ND −, − Control
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exon/exon boundaries to ensure specificity for variants; 
these were amplified and sequenced using end-point RT-
PCR to ensure specificity before performing RT-qPCR. 
Reactions contained 2 μL template cDNA (diluted 1/10–
1/40), 7.5  μL FastStart Universal SYBR Green Master 
(Rox) 2 × concentration (Roche, UK), 0.2–1.0 μL of each 
primer at 10  mM and nuclease-free water to 15  μL. All 
reactions were prepared using a CAS-1200™ Precision 
Liquid Handling System and performed on the Rotor-
Gene™ 3000 or Rotor-Gene Q (Qiagen). The amplifica-
tion profile used was the same for each gene except for 
the annealing temperature; 5 min at 94 °C, followed by 40 
cycles of 20 s at 94 °C, 20 s at optimized annealing tem-
perature for each primer set (Additional file 2) and 20 s at 
72 °C, followed by dissociation curve analysis to confirm 
a single gene product; amplicons were sequenced to con-
firm primer specificity. Relative expression levels were 
quantified in duplicate in three separate RT-qPCR runs, 
each time using cDNA from a different RT reaction, a no-
template control was included in all runs. Linearity and 
efficiency of PCR amplification was determined for each 
primer pair using a standard curve generated by a dilu-
tion series of a pool of sample cDNA. All reactions had 
an efficiency of  >90% and correlation coefficients   were 
R2 > 0.98 and a single peak melt curve.
Relative gene expression levels were calculated in 
GenEx 5 Standard Programme (MultiD Analyses AB, 
Sweden) using the comparative 2-(ΔΔ Cq) method and 
normalized to the geometric mean of YWHAZ and 
SDHA. Fold changes were calculated from ΔCq values 
using GenEx. The expression level in the three groups 
for each variant was analysed by one-way ANOVA; the 
difference between group means for each variant were 
analysed using Tukey’s multiple comparison test within 
one-way ANOVA, with a significance threshold of 
p ≤ 0.05.
Results
Cloning and sequencing identified six transcript variants 
of IL23R, five variants of IL12RB1, a single IL17RA tran-
script and four IL17RB variants (Table 2).
Characterization of sheep IL23R and IL12RB1
Sheep IL23R is encoded by 11 exons on the plus strand 
of chromosome 1 (NC_019458.1) and encodes a mature 
protein of 627 amino acids. IL23Rv1 has a 29  bp inser-
tion in the 5′ UTR (Chr1: 42  464  555–42  464  584) but 
has an identical predicted protein sequence to full length 
IL-23R (Additional file 3). IL23Rv2 has a 21 bp deletion 
(530–551) in exon 4 (Chr1: 42 476 073–42 476 094) that 
results in the loss of 7 amino acids (YVVYVKS) at amino 
acid positions 158–164 (151–157 in IL-23Rv2), and a 
2 bp insertion that causes a frame shift and a premature 
stop codon resulting in a protein of 287 amino acids 
(Additional file  3). IL23Rv3 has a 28  bp insertion (878–
906) in exon 6 (Chr1: 42 492 950–42 492 977) and is pre-
dicted to encode a truncated protein of 268 amino acids. 
IL23Rv4 does not contain exon 8 (Chr1: 42  512  417–
42  512  506) and encodes a 597 amino acid protein as a 
consequence of a 30 amino acid deletion (VPQVTMKS-
FQHDTQNSGLLIASIFKKHLTS); this causes the exci-
sion of the extracellular region. IL23v5 has a deletion of 
exon 9 (Chr1: 42 515 314–42 515 419) and is predicted to 
encode a truncated protein of 356 amino acids.
Sheep IL12RB1 is encoded by 16 exons on the plus 
strand of chromosome 5 (NC_019462.1) and is pre-
dicted to encode a protein of 730 amino acids. The 5′ 
UTR is at the 5′ end of exon 1, the extracellular region 
spans exons 1–13, the transmembrane region is encoded 
by exon 14 and the 3′ UTR is located at the 3′ end of 
exon 16. IL12RB1v1 contains a deletion from the 3′ end 
of exon 5 to exon 8 (Chr5: 4 857 176–4 859 356), which 
leads to a frame shift and a truncated protein of 185 
amino acids. IL12RB1v2 contains a 651 bp deletion span-
ning the 3′ end of exon 1 to the 5′ end of exon 7 (Chr5: 
4  853  183–4  858  549); this results in a 217 amino acid 
deletion at position 16–233 in the extracellular region. 
IL12RB1v3 contains a 528  bp deletion from exon 3 to 
exon 7 (Chr5: 4  855  325–4  858  535) that causes a 176 
amino acid deletion at position 51–226 within the extra-
cellular region (Additional file  3). IL12RB1v4 contains a 
deletion from the 3′ end of exon 4 to the 5′ end of exon 
9 (Chr5: 4 855 845–4 860 357) causing a frame shift and 
Table 2 Genbank accession numbers for the nucleotide 
and protein sequences of sheep IL12RB1, IL17RA, IL17RB 
and IL23R
Gene Nucleotide_id Protein_id
IL23R LN868336 CRX77112.1
IL23Rv1 LN868337 CRX77113.1
IL23Rv2 LN868338 CRX77114.1
IL23Rv3 LN868339 CRX77115.1
IL23Rv4 LN868340 CRX77116.1
IL23Rv5 LN868341 CRX77117.1
IL12RB1 LN878970 CUH82712.1
IL12RB1v1 LN878971 CUH82713.1
IL12RB1v2 LN878972 CUH82714.1
IL12RB1v3 LN878973 CUH82715.1
IL12RB1v4 LN878974 CUH82716.1
IL17RA LN878979 CUH82721.1
IL17RB LN878975 CUH82717.1
IL17RBv1 LN878976 CUH82718.1
IL17RBv2 LN878977 CUH82719.1
IL17RBv3 LN878978 CUH82720.1
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a truncated protein of 163 amino acids. All four IL12RB1 
splice variants are predicted to encode proteins contain-
ing the extracellular domain only.
Characterization of sheep IL17RA and IL17RB
Only one sheep IL17RA transcript was identified 
(Table  1). This is a partial sequence; the 5′ 1306  bp 
mapped to chromosome 3 of Oar v3.1 (NC_019460.1) 
with >99% identity; however the 3′ 581 bp did not map, 
as this region of Oar v3.1 genome assembly is incomplete. 
Comparison with human IL17RA transcript variants 
1 and 2 (NM_014339.6 and NM_001289905.1) shows 
that the sheep gene is orthologous to human variant 1 
as it contains the region encoded in humans by exon 11 
(Chr3: 212  818  526–212  818  627). The RT-qPCR prim-
ers used to quantify sheep IL17RA transcript expression 
were situated in exons 4 and 5.
Sheep IL17RB is encoded by 11 exons on the minus 
strand of chromosome 19 (NC_019476.1) and is pre-
dicted to encode a mature protein of 497 amino acids. 
The splice variant IL17RBv1 has a deletion of 96 bp (975–
1071) that results in a 32 amino acid deletion at position 
311 causing a truncated intracellular domain and the 
loss of the conserved TRAF6 binding motif. IL17RBv2 
has a complete deletion of exon 4 (Chr19: 47  056  667–
47 054 190) that causes a frame shift and a predicted pro-
tein of only 96 amino acids. IL17RBv3 has a deletion of 
exon 4 and a 177 bp insertion (651–828) at the 5′ end of 
exon 8 (Chr19: 47 050 145–47 049 971); this also results 
in a premature stop codon and a predicted protein of 96 
amino acids.
Quantification of receptor expression
RT-qPCR assays were developed and expression levels of 
the four cytokine receptor transcripts were quantified in 
the paucibacillary, multibacillary and uninfected, control 
animals. However only IL23R, IL12RB1 and IL12RB1v3 
and v4, IL17RA, IL17RB and IL17RBv2 and v3 could be 
accurately quantified; expression levels of all the others 
were too low for accurate measurement. Positive control 
assays, using a template sample known to contain the 
individual variants were used to confirm the reliability of 
the assay.
Of the IL23R and IL12RB1 variants only IL12RB1v3 
showed evidence of differential expression (Figure 1) with 
a significant 2.1-fold (p = 0.04) increase in expression in 
the multibacillary sheep in comparison to paucibacillary 
animals. Of the receptors for IL-25 (Figure  2), IL17RA 
was significantly higher (Table  3) in paucibacillary 
sheep when compared to both multibacillary (2.0-fold, 
p  =  0.001) and control sheep (2.2-fold, p  =  0.02). Full 
length IL17RB was significantly higher in the multibacil-
lary versus control comparison (2.49-fold, p = 0.04) but 
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Figure 1 Relative expression of IL23R and IL12RB1 transcript 
variants. RT-qPCR analysis of IL23R and IL12RB1 transcript variants 
in the ICLN of paucibacillary, multibacillary and uninfected control 
sheep. Results are expressed as ΔCq replicate means of individual 
animals; error bars are ±SD of the group. *p = ≤ 0.05.
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not in the other comparisons (although it was 2.08-fold 
higher in the multibacillary vs. paucibacillary compari-
son, but p = 0.08). No significant differential expression 
was seen with IL17RBv2 or v3.
Discussion
This study is the first investigation into structural, 
sequence and quantitative variation of expression of 
genes of the IL-23 and IL-25 receptor complexes, in 
relation to the different pathological forms of sheep 
paratuberculosis. Sequencing cDNA from the ICLN of 
paratuberculosis-diseased sheep identified multiple tran-
script variants of all genes except IL17RA.
Splice variation is a common feature of these genes 
in many species including humans. Ensembl 82 [35] 
reports four transcript variants and three protein-coding 
isoforms of human IL23R (ENSG00000162594). How-
ever up to 24 human isoforms have been identified [36] 
and similar patterns can be recognised in the sheep and 
human variants, with four sheep variants (IL23Rv2–v5) 
predicted to encode truncated proteins. IL23Rv2, v3 and 
v5 lack the transmembrane and intracellular domains 
and are likely not to encode cell receptors but to act as 
antagonists as has been described for human IL23R vari-
ants [36]. IL23Rv5 specifically lacks exon 10 (exon 9 in 
human IL23R) and is therefore equivalent to human 
IL23RΔ9, which is strongly linked to human IBD [26]. 
IL23Rv4 encodes a protein with a truncated extracellular 
domain, although as with all the variants IL23Rv4 retains 
the conserved WSXWS class 1 cytokine receptor activa-
tion motif [37]. However, none of the IL23R isoforms, 
including the full length form, was differential expressed 
in paratuberculosis. This is consistent with paratuber-
culosis in red deer [38], where IL23R showed no differ-
ence in expression in jejunal lymph nodes of animals 
with minimal (largely paucibacillary) or severe disease 
(multibacillary). Interestingly the ligand for the IL-23 
receptor (IL-23A) is significantly increased in paucibacil-
lary lesions but not in the draining lymph nodes [19]. In 
humans, the R318Q SNP protects against a number of 
immune-mediated diseases by reducing IL-23-mediated 
Th17 function [39]; this SNP was identified in the protein 
sequence translated from IL23R, IL23Rv1 and v4 nucleo-
tide sequences but no correlation with paratuberculosis 
pathology was identified.
All four IL12RB1 splice variants lack the WSXWS motif 
encoded within exon 7, suggesting that IL12RB1v1–v4 
are non-functional or that they can act as modulators 
of IL-12/IL-23 activity by ligand binding without sig-
nalling. A truncated IL12RB1Δtm variant lacking these 
domains has been identified in humans and mice [40]. In 
mice it is induced in dendritic cells (DC) after Mycobac-
terium tuberculosis infection [41]; expression promotes 
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Figure 2 Relative expression of IL17RA and IL17RB transcript 
variants. RT-qPCR analysis of IL17RA and IL17RB transcript variants 
in the ICLN of paucibacillary, multibacillary and uninfected control 
sheep. Results are expressed as ΔCq replicate means of individual 
animals; error bars are ±SD of the group. *p = ≤ 0.05, **p = ≤ 0.01.
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DC migration and may act to up-regulate IL-12RB1-
dependent DC function and the immune response to 
mycobacteria. Mendelian susceptibility to mycobacterial 
diseases (immunodeficiency 30) can partly be explained 
by IL12RB1 deficiency; some of these patients express 
5′-truncated IL12RB1 that encodes a non-functional pro-
tein incapable of binding IL-12 or IL-23 [42]. In the para-
tuberculosis studies only IL12RB1v3 was differentially 
expressed with a significant increase in multibacillary 
vs. paucibacillary sheep. This variant contains the trans-
membrane and intracellular domains but is 5′ truncated 
and does not possess the WSXWS cytokine receptor acti-
vation motif. Like the 5′ truncated human variant it may 
bind the cytokines but not transduce the signal, possibly 
contributing to the low level of IL-12/IL-23 driven Th1/
Th17 activity associated with multibacillary/lepromatous 
pathology.
Only a single sheep IL17RA transcript was identified. 
The predicted 5′ UTR of the sheep sequence shares 62.5% 
identity with the 5′ end of the human coding region 
(BC011624.2). Consequently the predicted sheep protein 
is only 249 amino acids rather than 866 amino acids of 
the full length human IL-17RA precursor (NP_055154.3). 
Two splice variants have been identified in humans, the 
full length transcript variant 1 (NM_014339.6) of 8607 bp 
and encoded by 13 exons and the soluble transcript vari-
ant 2 (NM_001289905.1) of 8506  bp without exon 11, 
which encodes the transmembrane domain [43]. How-
ever, no functional consequences have been associated 
with these variations. Sheep IL17RA includes exon 11 
and expression is significantly higher in paucibacillary 
disease in comparison to both multibacillary and unin-
fected controls. IL-17RA is a component of the recep-
tor (with IL-17RB) for both anti-inflammatory IL-25 and 
(with IL-17RC) the inflammatory Th17 cytokines IL-17A 
and IL-17F [44]; and high levels in paucibacillary animals 
could confirm a role of Th17 in paratuberculosis pathol-
ogy [10].
The three splice variants of sheep IL17RB are all pre-
dicted to encode truncated proteins. IL17RBv2 and v3 
encode identical short extracellular proteins that do not 
contain a transmembrane domain or intracellular region, 
it is therefore unlikely that they are cellular receptors but 
may bind and modulate IL-25 activity. The human trun-
cated isoform 2 (Q9NRM) [45] has an unknown function 
and is produced at very low levels due to a premature 
stop codon in the mRNA, leading to nonsense-mediated 
mRNA decay. IL17RBv1 also encodes a truncated pro-
tein, with an amino-terminal truncated SEFIR (similar 
expression to fibroblast growth factor genes and IL-17R) 
domain and no TRAF6 binding motif. The SEFIR domain 
mediates protein interactions necessary for receptor sig-
nal transduction [46] and TRAF6 binding is essential for 
IL-25-mediated expression of IL-6 and TGFβ [47].
Only full length IL17RB was differentially expressed 
in the paratuberculosis diseased sheep, expression in 
the ICLN of the multibacillary sheep was significantly 
greater (2.49-fold, p  =  0.04) than in uninfected con-
trols. The levels in paucibacillary and control animals 
were not significantly different. This argues that IL-25 
signalling is playing a role in multibacillary (leproma-
tous) pathology. IL-25 interaction with IL-17RA/IL-
17RB induces the production of the pro-inflammatory 
cytokines IL-6 and IL-8 by endothelia [48], and IL-4 
and IL-13 by T cells [49] leading to the development 
of Th2-associated pathology [50] especially at mucosal 
sites.
In conclusion, we have identified transcript variants 
in sheep of the four genes that make up the receptor 
complexes of IL-23 and IL-25; two cytokines important 
for the development of Th1/Th17 and Th2 T cells and 
in the pathogenesis of inflammatory disease at mucosal 
Table 3 Relative expression of cytokine receptor expression within the ICLN
Italics p ≤ 0.05.
a Fold change (ΔΔCq values).
Gene ANOVA
p value
Multi vs. control Pauci vs. control Multi vs. pauci
FCa p value FC p value FC p value
IL23R 0.501 0.6 0.97 1.35 0.54 0.98 0.99
IL12RB1 0.232 0.97 0.99 1.57 0.28 0.62 0.28
IL12RB1v3 0.049 1.42 0.32 −1.49 0.47 2.1 0.04
IL12RB1v4 0.079 1.1 0.89 −1.72 0.18 1.87 0.08
IL17RA 0.0016 0.46 0.43 2.2 0.02 −2.0 0.001
IL17RB 0.035 2.49 0.04 1.19 0.93 2.08 0.08
IL17RBv2 0.262 1.70 0.24 1.40 0.58 1.20 0.77
IL17RBv3 0.104 1.60 0.12 1.52 0.24 1.09 0.88
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surfaces. RT-qPCR analysis of the different variants 
highlighted the role of the amino-terminal truncated 
IL12RB1v3 and full length IL17RB in multibacil-
lary pathology; and full length IL17RA in paucibacil-
lary disease. This study of the gene structure, sequence 
and expression of IL-23 and IL-25 has provided an ini-
tial insight into the role of differential T cell activation 
associated with the two pathological forms of sheep 
paratuberculosis.
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